As of 2024-12-14, the Relative Valuation of Oncolytics Biotech Inc (ONC.TO) is (0.04) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.22 CAD, the upside of Oncolytics Biotech Inc based on Relative Valuation is -102.9%.
The range of the Relative Valuation is (0.03) - (0.07) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.2x | 0.1x |
| Forward P/E multiples | 0.1x - 0.2x | 0.1x |
| Fair Price | (0.03) - (0.07) | (0.04) |
| Upside | -102.4% - -105.9% | -102.9% |
| Date | P/E |
| 2024-11-29 | -3.68 |
| 2024-11-28 | -3.85 |
| 2024-11-27 | -3.62 |
| 2024-11-26 | -3.71 |
| 2024-11-25 | -3.65 |
| 2024-11-22 | -3.71 |
| 2024-11-21 | -3.82 |
| 2024-11-20 | -3.90 |
| 2024-11-19 | -4.13 |
| 2024-11-18 | -3.88 |
| 2024-11-15 | -3.85 |
| 2024-11-14 | -3.93 |
| 2024-11-13 | -4.10 |
| 2024-11-12 | -4.32 |
| 2024-11-11 | -4.15 |
| 2024-11-08 | -4.13 |
| 2024-11-07 | -4.18 |
| 2024-11-06 | -4.32 |
| 2024-11-05 | -4.54 |
| 2024-11-04 | -4.46 |
| 2024-11-01 | -4.63 |
| 2024-10-31 | -4.43 |
| 2024-10-30 | -4.60 |
| 2024-10-29 | -4.57 |
| 2024-10-28 | -4.74 |
| 2024-10-25 | -4.74 |
| 2024-10-24 | -4.82 |
| 2024-10-23 | -4.68 |
| 2024-10-22 | -4.88 |
| 2024-10-21 | -4.91 |
| 2024-10-18 | -5.16 |
| 2024-10-17 | -4.94 |
| 2024-10-16 | -4.80 |
| 2024-10-15 | -4.74 |
| 2024-10-11 | -4.77 |
| 2024-10-10 | -4.74 |
| 2024-10-09 | -5.05 |
| 2024-10-08 | -4.82 |
| 2024-10-07 | -5.33 |
| 2024-10-04 | -4.15 |
| 2024-10-03 | -3.54 |
| 2024-10-02 | -3.35 |
| 2024-10-01 | -3.29 |
| 2024-09-30 | -3.32 |
| 2024-09-27 | -3.35 |
| 2024-09-26 | -3.40 |
| 2024-09-25 | -3.43 |
| 2024-09-24 | -3.40 |
| 2024-09-23 | -3.43 |
| 2024-09-20 | -3.51 |